Kaposi sarcoma
Kaposi sarcoma
Updated: 10/21/2020
© Jun Wang, MD, PhD
General features
- Likely arising from endothelial cells
- 4 types
Epidemic AIDS-related
Most common presentation of Kaposi sarcoma
Incidence and severity reduced following the
introduction of HAART
CD4 count most important factor associated
with KS development
Early involvement of lymph nodes and gut and
wide dissemination
Relatively more aggressive
May develop lymphoma or another second
malignancy
Classic, or sporadic
More common in individuals from the
Mediterranean basin and Central and Eastern Europe or their descendants
More common in male
Higher risk if history of cancer
(commonly non-Hodgkin lymphoma) or altered immune state, but NOT with HIV
Mucosa of mouth and GI tract and regional
lymph nodes may be affected
Immunocompromised
Occurs months to years after high-dose
immunosuppressive therapy
Skin or metastatic lesions present
Skin lesions may regress if
immunosuppression is stopped
Usually fatal if spreads to viscera
Endemic (African)
Equatorial Africa
Adults: More common in male, involves skin, internal organs
Children: Both male and female, involves lymph nodes, internal organs, but NOT skin
Clinical presentations
- Non pruritic palpable mucocutaneous brown, pink,red, or violaceous macular, papular, nodular, or plaque like lesions
- Multicentric
- More common in lower extremities, head and neck
- Lymph nodes involvements
- Cutaneous KS staging
May be seen in all four types of KS
Macule/patch: Pink-purple macules; superficial or mid-dermal proliferation of capillary vessels
with inconspicuous spindle cell component
Plaque: Dermal, dilated vascular channels
dissect collagen with spindle cells and red blood cell extravasation; may have
nodal involvement
Nodule/tumor: More distinctly neoplastic,
spindle cells with intersecting fascicle like pattern; Small vessels and
slitlike spaces with rows of red blood cells; may have ulceration
Key pathogenesis
- Human herpesvirus 8 (HHV-8)
- HIV infected T cells, macrophages and dendritic cells produce various growth factors/cytokines promote transformation of HHV infected endothelial cells into spindle tumor cells
Key morphological features
Markers
- Positive for endothelial markers factor VIII–related antigen, CD31, and CD34
- Positive for lymphatic marker D2-40
- Positive for smooth muscle marker: smooth muscle actin
- Positive for HHV-8 and vimentin
Treatment
- Antiretroviral therapy: HAART
- Surgery, radiation, chemotherapy, cryotherapy, laser, etc.
Back to soft tissue tumors
Back to contents
Comments
Post a Comment